
Eli Lilly and Visa expected to hit $1 trillion valuation by 2030: Here’s what’s driving the surge
With global equity markets continuing their long-term expansion, industry observers are closely watching two companies that show strong potential to join the elite league of trillion-dollar firms by the end of this decade. Analysts point to Eli Lilly and …